Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg [Phase 3]
Phase 3 trial comparing safety and efficacy of aliskiren (300 mg, 150 mg, and 75 mg) versus ramipril (5 mg) in essential hypertension, with …
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations [Phase 2]
Phase 2 clinical trial update comparing rostafuroxin to losartan in hypertensive patients with specified gene mutations to evaluate antihype…
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension [Phase 2]
Phase 2 study evaluating the efficacy and safety of combining lercanidipine with valsartan in adults with essential hypertension has complet…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension [Phase 3]
Phase 3 trial comparing the fixed-dose combination valsartan/amlodipine to amlodipine alone in patients with essential hypertension; the stu…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension [Phase 2, Phase 3]
This clinical trial update reports on the efficacy and safety of a valsartan/amlodipine combination in adults with essential hypertension, e…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects [Phase 1]
Phase 1 study evaluating a single oral dose of fimasartan (BR-A-657) in healthy adult subjects to assess safety and pharmacokinetics, in the…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects [Phase 1]
Phase 1 multiple-ascending-dose study of fimasartan (BR-A-657) in healthy subjects to evaluate safety, tolerability, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension [Phase 2]
This Phase 2 trial evaluated the efficacy and safety of Azilsartan in adults with mild to moderate uncomplicated essential hypertension.
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Effects of a Structured Education Program on Blood Pressure in Essential Hypertensive Patients [NA]
This clinical trial evaluates whether a structured education program can reduce blood pressure in adults with essential hypertension.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension [Phase 4]
Phase 4 trial update on an aliskiren-based treatment algorithm showing efficacy and tolerability in patients with mild to moderate essential…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: In-practice Evaluation of Atacand 16mg Antihypertensive Effect
The document notes the completion of a real-world evaluation of Atacand 16 mg for essential hypertension to assess its antihypertensive effe…
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension [Phase 2]
Phase 2 trial assessing a vaccine against essential hypertension has completed, with results evaluating safety, tolerability, and preliminar…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension [Phase 4]
Phase 4 trial evaluating olmesartan with an add-on therapy in adults with mild to moderate essential hypertension; the study has completed a…
-
CLINICAL_TRIALS trial_result · 2010-10-14Clinical Trial Update: Olmesartan Medoxomil in Hypertension and Renal Impairment [Phase 3]
Phase 3 trial update reporting completion of a study evaluating olmesartan medoxomil in patients with essential hypertension and renal impai…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension [Phase 3]
Phase 3 trial evaluating the additional efficacy and safety of the fixed-dose combination olmesartan medoxomil 20 mg / hydrochlorothiazide 1…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension [Phase 3]
A Phase 3 study comparing olmesartan medoxomil with losartan potassium for essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea [Phase 4]
Phase 4 trial evaluating lacidipine in adults with type 2 diabetes and mild-to-moderate essential hypertension in Korea has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating the efficacy and safety of Topamax (topiramate) for treating obe…
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension [Phase 2]
The document reports the completion of a Phase 2 study evaluating a vaccine against essential hypertension, focusing on safety, tolerability…
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating the effect of fimasartan on the pharmacokinetics and safety of digoxin in healthy male volunteers.
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers [Phase 1]
Phase 1 study evaluating safety and pharmacokinetics of oral fimasartan in healthy elderly and young male volunteers has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers [Phase 1]
This Phase 1 trial update reports a completed pharmacokinetic interaction study to evaluate whether co-administration of fimasartan and amlo…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers [Phase 1]
A Phase 1 PK interaction study assessed whether atorvastatin affects the pharmacokinetics of fimasartan in healthy male volunteers to evalua…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating the effect of ketoconazole and rifampicin on the pharmacokinetics of fimasartan in healthy volunteers; the trial ha…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of co-administered fimasartan and hydrochlorothiazide in healthy male volunteers.